In situ RNA-RNA hybridisation of phospholipase C β3 shows lack of expression in neuroendocrine tumours

Anticancer Research

Volumn 23, Issue 3 B, 2003, Pages 2227-2232

  Stålberg, Peter ^a   Granberg, Dan ^a   Carling, Tobias ^a   Wilander, Erik ^a   Eriksson, Barbro ^a   Gobl, Anders ^a   Akerström, Goran ^a   Rastad, Jonas ^a   Modlin, Irvin M ^b   Öberg, Kjell ^a   Skogseid, Briti ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

In situ hybridisation; Neuroendocrine tumours; Phospholipase C 3 (PLCB3)

Indexed keywords

MEMBRANE PROTEIN; MEMBRANE RECEPTOR; PHOSPHOLIPASE C; PHOSPHOLIPASE C BETA3; UNCLASSIFIED DRUG;

ARTICLE; BRONCHUS CARCINOID; CARCINOGENESIS; CHROMOSOME 11Q; GENE EXPRESSION REGULATION; GENE LOCATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MEN1 GENE; MISMATCH REPAIR; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; NEUROSECRETORY CELL; PANCREAS CANCER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA RNA HYBRIDIZATION; SIGNAL TRANSDUCTION;

ANIMALS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ISOENZYMES; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; MURIDAE; NEUROENDOCRINE TUMORS; PHOSPHOLIPASE C; RNA, NEOPLASM;

EID: 0042808411     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Larsson C, Skogseid B, Oberg K, Nakamura Y and Nordenskjold M: Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332: 85-7, 1988.
2. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL and Marx SJ: Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276: 404-7, 1997.
3. Lemmens I, Van de Ven WJ, Kas K, Zhang CX, Giraud S, Wautot V, Buisson N, De Witte K, Salandre J, Lenoir G, Pugeat M, Calender A, Parente F, Quincey D, Gaudray P, De Wit MJ, Lips CJ, Hoppener JW, Khodaei S, Grant AL, Weber G, Kytola S, Teh BT, Farnebo F and Thakker RV et al: Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum Mol Genet 6: 1177-83, 1997.
4. Tanaka C, Kimura T, Yang P, Moritani M, Yamaoka T, Yamada S, Sano T, Yoshimoto K and Itakura M: Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas. J Clin Endocrinol Metab 83: 2631-4, 1998.
5. Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR, Guru SC, Manickam P, Olufemi SE, Skarulis MC, Doppman JL, Alexander RH, Kim YS, Saggar SK, Lubensky IA, Zhuang Z, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL and Marx SJ: Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet 16: 375-8, 1997.
6. Hessman O, Lindberg D, Skogseid B, Carling T, Hellman P, Rastad J, Akerstrom G and Westin G: Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumours of the endocrine pancreas. Cancer Res 58: 377-9, 1998.
7. Wang EH, Ebrahimi SA, Wu AY, Kashefi C, Passaro E Jr and Sawicki MP: Mutation of the MENIN gene in sporadic pancreatic endocrine tumours. Cancer Res 58: 4417-20, 1998.
8. Weber G, Friedman E, Grimmond S, Hayward NK, Phelan C, Skogseid B, Gobl A, Zedenius J, Sandelin K, Teh BT, Carson E, White I, Oberg K, Shepherd J, Nordenskioid M and Larsson C: The phospholipase C beta 3 gene located in the, MEN1 region shows loss of expression in endocrine tumours. Hum Mol Genet 3: 1775-81, 1994.
9. Weber G, Grimmond S, Lagercrantz J, Friedman E, Phelan C, Carson E, Hayward N, Jacobovitz O, Nordenskjold M and Larsson C: Exclusion of the phosphoinositide-specific phospholipase C beta 3 (PLCB3) gene as a candidate for multiple endocrine neoplasia type 1. Hum Genet 99: 130-2, 1997.
10. Heppner C, Reincke M, Agarwal SK, Mora P, Allolio B, Burns AL, Spiegel AM and Marx SJ: MEN1 gene analysis in sporadic adrenocortical neoplasms. J Clin Endocrinol Metab 84: 216-9, 1999.
11. Kjellman M, Roshani L, Teh BT, Kallioniemi OP, Hoog A, Gray S, Farnebo LO, Holst M, Backdahl M and Larsson C: Genotyping of adrenocortical tumours: very frequent deletions of the MEN1 locus in 11q13 and of a 1-centimorgan region in 2p16. J Clin Endocrinol Metab 84: 730-5, 1999.
12. Nord B, Larsson C, Wong FK, Wallin G, Teh BT and Zedenius J: Sporadic follicular thyroid tumours show loss of a 200-kb region in 11q13 without evidence for mutations in the MEN1 gene. Genes Chromosomes Cancer 26: 35-9, 1999.
13. Stålberg P, Wang S, Larsson C, Weber G, Oberg K, Gobl A and Skogseid B: Suppression of the neoplastic phenotype by transfection of phospholipase C beta 3 to neuroendocrine tumour cells [In Process Citation]. FEBS Lett 450: 210-6, 1999.
14. Stålberg P, Lopez-Egido JR, Wang S, Gobl A, Oberg K and Skogseid B: Differentially expressed cDNAs in PLCbeta3-induced tumour suppression in a human endocrine pancreatic tumour cell line: Activation of the human mismatch repair protein 3 gene. Biochem Biophys Res Commun 281: 227-231, 2001.
15. Van Biesen T, Luttrell LM, Hawes BE and Lefkowitz RJ: Mitogenic signaling via G protein-coupled receptors. Endocr Rev 17: 698-714, 1996.
16. Parekh D, Ishizuka J, Townsend CM Jr, Haber B, Beauchamp RD, Karp G, Kim SW, Rajaraman S, Greeley G Jr and Thompson JC: Characterization of a human pancreatic carcinoid in vitro: morphology, amine and peptide storage, and secretion. Pancreas 9: 83-90, 1994.
17. Bilchik AJ, Nilsson O, Modlin IM, Zucker KA and Adrian TE: Significance of gastric endocrine tumour and age-related gut peptide alterations in Mastomys. Regul Pept 27: 195-207, 1990.
18. Stridsberg M, Hellman U, Wilander E, Lundqvist G, Hellsing K and Oberg K: Fragments of chromogranin A are present in the urine of patients with carcinoid tumours: development of a specific radioimmunoassay for chromogranin A and its fragments. J Endocrinol 139: 329-37, 1993.
19. Skogseid B, Rastad J, Gobl A, Larsson C, Backlin K, Juhlin C, Akerstrom G and Oberg K: Adrenal lesion in multiple endocrine neoplasia type 1. Surgery 118: 1077-82, 1995.
20. Thakker RV, Bouloux P, Wooding C, Chotai K, Broad PM, Spurr NK, Besser GM and O'Riordan JL: Association of parathyroid tumours in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med 321: 218-24, 1989.
21. Bystrom C, Larsson C, Blomberg C, Sandelin K, Falkmer U, Skogseid B, Oberg K, Werner S and Nordenskjold M: Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumours. Proc Natl Acad Sci USA 87: 1968-72, 1990.
22. Debelenko LV, Brambilla E, Agarwal SK, Swalwell JI, Kester MB, Lubensky IA, Zhuang Z, Guru SC, Manickam P, Olufemi SE, Chandrasekharappa SC, Crabtree JS, Kim YS, Heppner C, Burns AL, Spiegel AM, Marx SJ, Liotta LA, Collins FS, Travis WD and Emmert-Buck MR: Identification of MEN1 gene mutations in sporadic carcinoid tumours of the lung. Hum Mol Genet 6: 2285-90, 1997.
23. Camby I, Nagy N, Lopes MB, Schafer BW, Maurage CA, Ruchoux MM, Murmann P, Pochet R, Heizmann CW, Brotchi J, Salmon I, Kiss R and Decaestecker C: Supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas are characterized by a differential expression of S100 proteins. Brain Pathol 9: 1-19, 1999.
24. Lloyd BH, Ruddell C, Rudland PS and Barraclough R: S100A3 mRNA expression displays an inverse correlation to breast cancer progression. Biochem Soc Trans 24: 340S, 1996.
25. Akiyama Y, Tsubouchi N and Yuasa Y: Frequent somatic mutations of hMSH3 with reference to microsatellite instability in hereditary nonpolyposis colorectal cancers. Biochem Biophys Res Commun 236: 248-52, 1997.
26. Inokuchi K, Ikejima M, Watanabe A, Nakajima E, Orimo H, Nomura T and Shimada T: Loss of expression of the human MSH3 gene in hematological malignancies. Biochem Biophys Res Commun 214: 171-9, 1995.
27. Martelli AM, Billi AM, Gilmour RS, Neri LM, Manzoli L, Ognibene A and Cocco L: Phosphoinositide signaling in nuclei of Friend cells: phospholipase C beta down-regulation is related to cell differentiation. Cancer Res 54: 2536-40,. 1994.
28. Cocco L, Rubbini S, Manzoli L, Billi AM, Faenza I, Peruzzi D, Matteucci A, Artico M, Gilmour RS and Rhee SG: Inositides in the nucleus: presence and characterisation of the isozymes of phospholipase beta family in NIH 3T3 cells. Biochim Biophys Acta 1438: 295-9, 1999.
29. Wang S, Lukinius A, Zhou Y, Stalberg P, Gobl A, Oberg K and Skogseid B: Subcellular distribution of phospholipase C isoforms in rodent pancreas and gastric mucosa. Endocrinology 141: 2589-93, 2000.
30. Marcand S, Gasser SM and Gilson E: Chromatin: a sticky silence. Curr Biol 6: 1222-5, 1996.
31. Katan M: Families of phosphoinositide-specific phospholipase C: structure and function. Biochim Biophys Acta 1436: 5-17, 1998.
32. Agarwal SK, Guru SC, Heppner C, Erdos MR, Collins RM, Park SY, Saggar S, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ and Burns AL: Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96: 143-52, 1999.
33. Gobl AE, Berg M, Lopez-Egido JR, Oberg K, Skogseid B and Westin G: Menin represses JunD-activated transcription by a histone deacetylase-dependent mechanism. Biochim Biophys Acta 1447: 51-6, 1999.